Pursuant to regulation 29 and 30 of SEBI LODR, Amrutanjan Healthcare has informed that a meeting of the Board of Directors is scheduled to be held on Thursday, November 9, 2017 at the registered office of the Company to consider and approve the Un-audited Financial Results along with the Limited Review Report for the quarter and half year ended September 30, 2017; and declaration of 1st interim dividend for the financial year 2017-18. In view of the above, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct to regulate, monitor and report trading by insiders, the trading window for dealing in the securities of the Company shall remain closed for the Specified Persons (Directors & Designated Employees) from November 2, 2017 to November 12, 2017.
The above information is a part of company’s filings submitted to BSE.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1948.90 |
Dr. Reddys Lab | 6746.05 |
Cipla | 1671.60 |
Lupin | 2213.50 |
Zydus Lifesciences | 1074.60 |
View more.. |